Thus, it is clear that an effect of a drug on reward in non-obese animals cannot be simply extrapolated to those that are obese and it will be crucial to determine whether the food reward suppressive effects of GLP-1 and analogs is relevant and beneficial in an obese model
active optimization is part of your plan
Water, Methylpropanediol, Niacinamide(50,000ppm), PEG/PPG-17/6 Copolymer, Coptis Japonica Root Extract, 1,2-Hexanediol, Hydroxyacetophenone, Hydroxyethyl Urea, Isopentyldiol, Methyl Gluceth-20, Carbomer, Allantoin, Sodium Ascorbyl Phosphate(1,000ppm), Glutathione(500ppm), Hydrogenated Lecithin, PEG-60 Hydrogenated Castor Oil, Xanthan Gum, Adenosine, Ethylhexylglycerin, Sodium Polyacrylate, Butylene Glycol, Centella Asiatica Extract, Disodium EDTA, Hydroxyethylcellulose, Methyl Diisopropyl Propionamide, Polyglutamic Acid, Protease, Ceramide NP, Ascorbic Acid(10,000ppb), Arbutin, Bisabolol, Hyaluronic Acid
However, a similar number of participants across all groups reported increases in sweetness (Wegovy 19.4%, Ozempic 21.6%, Mounjaro 21.7%)